Skip to main navigation Skip to search Skip to main content

Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.

  • Heather D. Brooks
  • , Bonnie S Glisson
  • , B. Nebiyou Bekele
  • , Lawrence E Ginsberg
  • , Adel K El-Naggar
  • , Kirk S. Culotta
  • , Naoko Takebe
  • , John Wright
  • , Hai T Tran
  • , Vassiliki A Papadimitrakopoulou
  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalCancer
Volume117
Issue number10
DOIs
StatePublished - May 15 2011
Externally publishedYes

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Surgery
  • Internal Medicine

Cite this